{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:28:42Z","timestamp":1790026122083,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40360-018-0243-0","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T18:43:24Z","timestamp":1535568204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Survivability of hospitalized chronic kidney disease (CKD) patients with moderate to severe estimated glomerular filtration rate (eGFR) after experiencing adverse drug reactions (ADRs) in a public healthcare center: a retrospective 3 year study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6850-8482","authenticated-orcid":false,"given":"Monica","family":"Danial","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Azmi","family":"Hassali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loke Meng","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer Hayat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"243_CR1","doi-asserted-by":"crossref","unstructured":"Tan Y, Hu Y, Liu X, Yin Z, Chen XW and Liu M. Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation. Methods (San Diego, Calif). 2016.","DOI":"10.1016\/j.ymeth.2016.07.023"},{"key":"243_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","volume-title":"Mechanisms of acetaminophen-induced liver necrosis. Adverse Drug Reactions","author":"JA Hinson","year":"2010","unstructured":"Hinson JA, Roberts DW, James LP. Mechanisms of acetaminophen-induced liver necrosis. Adverse Drug Reactions. Berlin, Heidelberg: Springer; 2010. p. 369\u2013405."},{"key":"243_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1345\/aph.1P592","volume":"46","author":"G Shepherd","year":"2012","unstructured":"Shepherd G, Mohorn P, Yacoub K, May DW. Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. Ann Pharmacother. 2012;46:169\u201375.","journal-title":"Ann Pharmacother"},{"key":"243_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ejim.2007.06.030","volume":"19","author":"A Alexopoulou","year":"2008","unstructured":"Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Int Med. 2008;19:505\u201310.","journal-title":"Eur J Int Med"},{"key":"243_CR5","doi-asserted-by":"publisher","unstructured":"Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ. 1998;316(7140):1295\u20138. https:\/\/doi.org\/10.1136\/bmj.316.7140.1295","DOI":"10.1136\/bmj.316.7140.1295"},{"key":"243_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jsps.2012.09.004","volume":"21","author":"LM Khan","year":"2013","unstructured":"Khan LM, Al-Harthi SE, Saadah OI. Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University hospital and impact of pharmacovigilance in reporting ADR. Saudi Pharmaceutical J. 2013;21:261\u20136.","journal-title":"Saudi Pharmaceutical J"},{"key":"243_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/pds.1138","volume":"14","author":"AF Macedo","year":"2005","unstructured":"Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf. 2005;14:885\u201390.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"243_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jsps.2014.04.008","volume":"24","author":"TM Alshammari","year":"2016","unstructured":"Alshammari TM. Drug safety: the concept, inception and its importance in patients\u2019 health. Saudi Pharmaceutical J. 2016;24:405\u201312.","journal-title":"Saudi Pharmaceutical J."},{"key":"243_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1472-8206.2007.00473.x","volume":"21","author":"SN Hilmer","year":"2007","unstructured":"Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol. 2007;21:217\u201330.","journal-title":"Fundam Clin Pharmacol"},{"key":"243_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00228-004-0869-2","volume":"61","author":"Y Arimone","year":"2005","unstructured":"Arimone Y, Begaud B, Miremont-Salame G, et al. Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol. 2005;61:169\u201373.","journal-title":"Eur J Clin Pharmacol"},{"key":"243_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2710.2003.00475.x","volume":"28","author":"AF Macedo","year":"2003","unstructured":"Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther. 2003;28:137\u201343.","journal-title":"J Clin Pharm Ther"},{"key":"243_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jsps.2015.01.010","volume":"24","author":"LM Khan","year":"2016","unstructured":"Khan LM, Al-Harthi SE, Osman AMM, Sattar MAAA, Ali AS. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharmaceutical J. 2016;24:485\u201393.","journal-title":"Saudi Pharmaceutical J"},{"key":"243_CR13","first-page":"2229","volume":"49","author":"SC Hartwig","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229\u201332.","journal-title":"Am J Hosp Pharm"},{"key":"243_CR14","first-page":"2611","volume":"48","author":"SC Hartwig","year":"1991","unstructured":"Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm. 1991;48:2611\u20136.","journal-title":"Am J Hosp Pharm"},{"key":"243_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.7326\/0003-4819-60-1-100","volume":"60","author":"EM Schimmel","year":"1964","unstructured":"Schimmel EM. The Hazards of Hospitalization. Ann Intern Med. 1964;60:100\u201310.","journal-title":"Ann Intern Med"},{"key":"243_CR16","doi-asserted-by":"publisher","unstructured":"Aronson J. Stephens\u2019 detection of new adverse drug reactions, 5th edn. Br J Clin Pharmacol. 2004;58(2):227. https:\/\/doi.org\/10.1111\/j.1365-2125.2004.02121.x .","DOI":"10.1111\/j.1365-2125.2004.02121.x"},{"key":"243_CR17","unstructured":"Rawlins MD and Thompson JW. Pathogenesis of adverse drug reactions. In: (ed.) DD, (ed.). In Textbook of Adverse Reactions 1977, p. 44."},{"key":"243_CR18","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1001\/jama.2012.3954","volume":"307","author":"K Matsushita","year":"2012","unstructured":"Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307:1941\u201351.","journal-title":"JAMA"},{"key":"243_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7326\/0003-4819-158-8-201304160-00004","volume":"158","author":"N Tangri","year":"2013","unstructured":"Tangri N, Kitsios GD, Inker LA, et al. Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med. 2013;158:596\u2013603.","journal-title":"Ann Intern Med"},{"key":"243_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/MNH.0b013e328359072f","volume":"21","author":"C Rigatto","year":"2012","unstructured":"Rigatto C, Sood MM, Tangri N. Risk prediction in chronic kidney disease: pitfalls and caveats. Curr Opin Nephrol Hypertens. 2012;21:612\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"243_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ (Clinical research ed). 2004;329:15\u20139.","journal-title":"BMJ (Clinical research ed)"},{"key":"243_CR22","doi-asserted-by":"publisher","unstructured":"Wiggins BS, Saseen JJ, Page RL 2nd, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB; on behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; Council on Quality of Care and Outcomes Research; and Council on Functional Genomics and Translational Biology. Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2016;134:e468\u2013e495. https:\/\/doi.org\/10.1161\/CIR.0000000000000456 .","DOI":"10.1161\/CIR.0000000000000456"},{"key":"243_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"243_CR24","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet (London, England). 2000;356:1255\u20139.","journal-title":"Lancet (London, England)"},{"key":"243_CR25","first-page":"18","volume-title":"Textbook of Adverse Drug Reactions","author":"MD Rawlins","year":"1991","unstructured":"Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM, editor. Textbook of Adverse Drug Reactions. Oxford: Oxford University Press; 1991. p. 18\u201345."},{"key":"243_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"243_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2796.1990.tb00199.x","volume":"228","author":"J Hallas","year":"1990","unstructured":"Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228:83\u201390.","journal-title":"J Intern Med"},{"key":"243_CR28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression Models and Life-tables. J R Stat Soc Ser B Methodol. 1972;34:187\u2013220.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"243_CR29","unstructured":"Cox DR, Oakes D. Analysis of Survival Data. 1st ed. London: Chapman and Hall; 1984, p. 212."},{"key":"243_CR30","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2215\/CJN.00180115","volume":"10","author":"LA Inker","year":"2015","unstructured":"Inker LA, Tighiouart H, Aspelund T, et al. Lifetime risk of stage 3-5 CKD in a community-based sample in Iceland. Clin J Am Soc Nephrol. 2015;10:1575\u201384.","journal-title":"Clin J Am Soc Nephrol"},{"key":"243_CR31","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200\u20135.","journal-title":"JAMA"},{"key":"243_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004439","volume":"4","author":"EC Davies","year":"2009","unstructured":"Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4:e4439.","journal-title":"PLoS One"},{"key":"243_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1445-5994.2001.00044.x","volume":"31","author":"M Chan","year":"2001","unstructured":"Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31:199\u2013205.","journal-title":"Intern Med J"},{"key":"243_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","volume":"63","author":"RL Howard","year":"2007","unstructured":"Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136\u201347.","journal-title":"Br J Clin Pharmacol"},{"key":"243_CR35","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","volume":"365","author":"DS Budnitz","year":"2011","unstructured":"Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002\u201312.","journal-title":"N Engl J Med"},{"key":"243_CR36","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2012.16817","volume":"308","author":"SI Hallan","year":"2012","unstructured":"Hallan SI, Matsushita K, Sang Y, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012;308:2349\u201360.","journal-title":"JAMA"},{"key":"243_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1053\/j.ajkd.2013.03.009","volume":"62","author":"ME Grams","year":"2013","unstructured":"Grams ME, Chow EK, Segev DL, Coresh J. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis. 2013;62:245\u201352.","journal-title":"Am J Kidney Dis"},{"key":"243_CR38","first-page":"E3","volume":"2","author":"M Kvasz","year":"2000","unstructured":"Kvasz M, Allen IE, Gordon MJ, et al. Adverse drug reactions in hospitalized patients: a critique of a meta-analysis. MedGenMed. 2000;2:E3.","journal-title":"MedGenMed"},{"key":"243_CR39","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1681\/ASN.2014060607","volume":"26","author":"L Fan","year":"2015","unstructured":"Fan L, Levey AS, Gudnason V, et al. Comparing GFR estimating equations using cystatin C and creatinine in elderly individuals. J Am Soc Nephrol. 2015;26:1982\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"243_CR40","doi-asserted-by":"publisher","first-page":"187103","DOI":"10.1155\/2011\/187103","volume":"2011","author":"OP Soldin","year":"2011","unstructured":"Soldin OP, Chung SH, Mattison DR. Sex differences in drug disposition. J Biomed Biotechnol. 2011;2011:187103.","journal-title":"J Biomed Biotechnol"},{"key":"243_CR41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1053\/j.ajkd.2015.04.041","volume":"66","author":"EM Doyle","year":"2015","unstructured":"Doyle EM, Sloan JM, Goodbrand JA, et al. Association between kidney function, rehabilitation outcome, and survival in older patients discharged from inpatient rehabilitation. Am J Kidney Dis. 2015;66:768\u201374.","journal-title":"Am J Kidney Dis"},{"key":"243_CR42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1471-2369-14-228","volume":"14","author":"SR Walker","year":"2013","unstructured":"Walker SR, Gill K, Macdonald K, et al. Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol. 2013;14:228.","journal-title":"BMC Nephrol"},{"key":"243_CR43","doi-asserted-by":"publisher","unstructured":"Bowling CB, Sawyer P, Campbell RC, Ahmed A, Allman RM. Impact of chronic kidney disease on activities of daily living in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2011;66(6):689\u201394. https:\/\/doi.org\/10.1093\/gerona\/glr043","DOI":"10.1093\/gerona\/glr043"},{"key":"243_CR44","doi-asserted-by":"publisher","unstructured":"Fried LF, Lee JS, Shlipak M, Chertow GM, Green C, Ding J, Harris T, Newman AB. Chronic kidney disease and functional limitation in older people: health, aging and body composition study. J Am Geriatr Soc. 2006;54(5):750\u201356. https:\/\/doi.org\/10.1111\/j.1532-5415.2006.00727.x","DOI":"10.1111\/j.1532-5415.2006.00727.x"},{"key":"243_CR45","doi-asserted-by":"publisher","first-page":"e44S","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e44S\u201388S.","journal-title":"Chest"},{"key":"243_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"243_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2042098615615472","volume":"7","author":"AH Lavan","year":"2016","unstructured":"Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Therapeutic Advances in Drug Safety. 2016;7:11\u201322.","journal-title":"Therapeutic Advances in Drug Safety"},{"key":"243_CR48","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","volume":"35","author":"JS Gottdiener","year":"2000","unstructured":"Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2000;35:1628\u201337.","journal-title":"J Am Coll Cardiol"},{"key":"243_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2165\/00003088-198815050-00002","volume":"15","author":"KW Woodhouse","year":"1988","unstructured":"Woodhouse KW, Wynne HA. Age-related changes in liver size and hepatic blood flow. Clin Pharmacokinet. 1988;15:287\u201394.","journal-title":"Clin Pharmacokinet"},{"key":"243_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bcp.12615","volume":"80","author":"L Morin","year":"2015","unstructured":"Morin L, Fastbom J, Laroche ML, Johnell K. Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates. Br J Clin Pharmacol. 2015;80:315\u201324.","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"243_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/bcp.12127","volume":"76","author":"A Neubert","year":"2013","unstructured":"Neubert A, Dormann H, Prokosch HU, et al. E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions. Br J Clin Pharmacol. 2013;76(Suppl 1):69\u201377.","journal-title":"Br J Clin Pharmacol"},{"key":"243_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1197\/jamia.M2667","volume":"15","author":"E Ammenwerth","year":"2008","unstructured":"Ammenwerth E, Schnell-Inderst P, Machan C, Siebert U. The effect of electronic prescribing on medication errors and adverse drug events: a systematic review. J Am Med Inform Assoc. 2008;15:585\u2013600.","journal-title":"J Am Med Inform Assoc"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-018-0243-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-018-0243-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-018-0243-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T18:45:12Z","timestamp":1720550712000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-018-0243-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1186\/s40360-018-0243-0","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out after obtaining the approval to access the medical records for the purposes of this study from the Medical Research & Ethics Committee (MREC), Ministry of Health Malaysia (MOH). Study approval number: NMRR-15-1810-28,375(IIR).The need to obtain consent from study participants was waived as there is no direct interaction with the study participants in accordance with the Medical Research & Ethics Committee (MREC), Ministry of Health Malaysia (MOH) regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests..","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"52"}}